Billionaire Profile
Viktor Kharitonin
Global Rank
#462

Image: kremlin.ru | CC BY 4.0 | via Wikimedia Commons

Viktor Kharitonin

CEO, Pharmaceuticals
RUSSIA
Real-Time Net Worth
$7.858B
Estimated based on Pharmaceuticals stock value as of April 20, 2026
0% (24h)
Age
53
Source
Pharmaceuticals
Industry
Healthcare
Citizenship
RUSSIA

Biography

Viktor Kharitonin is a prominent Russian billionaire with a net worth of $7.9 billion as of March 25, 2026. His wealth primarily stems from his successful ventures in the pharmaceuticals industry. He co-founded Pharmstandard in 2003, a multinational pharmaceutical company, and played a pivotal role in its growth. His career is characterized by strategic investments and a keen understanding of the pharmaceutical market, which led to significant achievements including listing Pharmstandard on the London Stock Exchange.

Fact Checked
Verified by Editorial Team
Live Data
Updated 4/20/2026

Wealth Over Time

In-Depth Profile

Early Life and Education

Viktor Kharitonin was born on November 20, 1972, in Novosibirsk, Russia. He graduated from Novosibirsk State University with a Master of Science degree.

Rise to Success

Kharitonin's career began in the investment sector. In 1999, he founded Profit House, an investment company that worked closely with Roman Abramovich's Millhouse Capital. His trajectory shifted in 2003 when he co-founded Pharmstandard with Roman Abramovich and other partners. Pharmstandard was created by combining five pharmaceutical plants. Kharitonin, along with partner Egor Kulkov, acquired the other investors' stakes in 2008.

Key Business Strategies

A key strategy for Kharitonin was the acquisition and consolidation of pharmaceutical assets. He expanded Pharmstandard's portfolio to include over 400 generic and proprietary drugs. Furthermore, he took Pharmstandard private again eight years after its IPO. He also holds stakes in other Russian pharmaceutical companies like OTCPharm, Biocad, and Generium. In 2021, he acquired TSS group, an equipment manufacturing firm, through Augment Investments.

Philanthropy

Information on specific amounts of philanthropy could not be found via search results. It is known that Kharitonin owns the Nürburgring race track in Germany.

Career Milestones

1999

Founded Profit House

Founded an investment company involved in securities market operations.

2003

Co-founded Pharmstandard

Co-founded a pharmaceutical company with Roman Abramovich.

2008

Listed Pharmstandard on London Stock Exchange

Successfully listed the pharmaceutical firm.

2016

Took Pharmstandard private

Took the company private again.

2021

Acquired TSS group

Acquired the equipment manufacturing firm through Augment Investments.

Philanthropy & Social Impact

Sports

Nürburgring Race Track

$87M

Kharitonin purchased the Nürburgring race track in Germany.